Methylprednisolone bolus in ankylosing spondylitis

Juan Carlos Duró, Joan Maymo, Anna Lafont, Jordi Carbonell

    Research output: Contribution to journalArticleResearchpeer-review


    For several years the medical treatment of active ankylosing spondylitis (AS) has been NSAID. Steroids have not shown efficacy. In 1981 Mintz et al reported that methylprednisolone pulse therapy had an excellent effect in patients with AS. Six patients with active AS and no efficacy with NSAID were treated with 1 gram methyl prednisolone daily given intravenously for three successive days. Significant pain relief were clearly demonstrated. We conclude that intravenous MPPT is a useful treatment in patients with active AS when NSAID are not effective.
    Original languageEnglish
    Pages (from-to)92-94
    JournalRevista Espanola de Reumatologia
    Issue number3
    Publication statusPublished - 1 Mar 1997


    Dive into the research topics of 'Methylprednisolone bolus in ankylosing spondylitis'. Together they form a unique fingerprint.

    Cite this